IL-17C promotes tumor-associated inflammation and lung tumor growth

Christopher Jungnickel (Homburg, Germany), Christopher Jungnickel, Lina Bittigkoffer, Andreas Kamyschnikow, Christian Herr, Robert Bals, Christoph Beisswenger

Source: International Congress 2016 – Late-breaking translational research in lung cancer
Session: Late-breaking translational research in lung cancer
Session type: Oral Presentation
Number: 1529
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christopher Jungnickel (Homburg, Germany), Christopher Jungnickel, Lina Bittigkoffer, Andreas Kamyschnikow, Christian Herr, Robert Bals, Christoph Beisswenger. IL-17C promotes tumor-associated inflammation and lung tumor growth. Eur Respir J 2016; 48: Suppl. 60, 1529

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013


The roles of Ki-67, p53, transforming growth factor- and lysyl oxidase in the metastasis of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumour metastasis
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

pDC induced Treg proliferation through PD-1/PD-L1 signal and promote tumor immune escape of lung cancer with MPE
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Tumor cell-derived osteopontin promotes lung metastasis via both cell-autonomous and paracrine pathways
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016

Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

COPD-like inflammation drives the progression of K-ras induced early cancerous lesions
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015


Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Recombination of B7-H4 and CD68 predicted lymph node metastasis in human lung carcinoma
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Macrophages promote urethane-induced lung adenocarcinoma
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

The role of HIF-1 pathway in non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

The prognostic impact of PD1 and PDL1 expression in non-small cell lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016